Search Results - "Ralph, Schulz"

Refine Results
  1. 1
  2. 2

    Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia by Giménez, Neus, Schulz, Ralph, Higashi, Morihiro, Aymerich, Marta, Villamor, Neus, Delgado, Julio, Juan, Manel, López-Guerra, Mònica, Campo, Elias, Rosich, Laia, Seiffert, Martina, Colomer, Dolors

    Published in Leukemia (01-01-2020)
    “…Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in Toll-like receptor (TLR) signal transduction and innate immune responses…”
    Get full text
    Journal Article
  3. 3

    Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice by Hanna, Bola S, Yazdanparast, Haniyeh, Demerdash, Yasmin, Roessner, Philipp M, Schulz, Ralph, Lichter, Peter, Stilgenbauer, Stephan, Seiffert, Martina

    Published in Haematologica (Roma) (01-04-2021)
    “…Ibrutinib is a bruton's tyrosine kinase (BTK) inhibitor approved for the treatment of multiple B-cell malignancies, including chronic lymphocytic leukemia…”
    Get full text
    Journal Article
  4. 4

    Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome by Nuber, Ulrike A., Kriaucionis, Skirmantas, Roloff, Tim C., Guy, Jacky, Selfridge, Jim, Steinhoff, Christine, Schulz, Ralph, Lipkowitz, Bettina, Ropers, H. Hilger, Holmes, Megan C., Bird, Adrian

    Published in Human molecular genetics (01-08-2005)
    “…Rett syndrome (RTT) is a severe form of mental retardation, which is caused by spontaneous mutations in the X-linked gene MECP2. How the loss of MeCP2 function…”
    Get full text
    Journal Article
  5. 5

    Divisible designs with dual translation group by Giese, Sabine, Schulz, Ralph-Hardo

    Published in Designs, codes, and cryptography (01-04-2007)
    “…Many different divisible designs are already known. Some of them possess remarkable automorphism groups, so called dual translation groups. The existence of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Some constructions of divisible designs from Laguerre geometries by Giese, Sabine, Havlicek, Hans, Schulz, Ralph-Hardo

    Published in Discrete mathematics (28-09-2005)
    “…In the nineties, A.G. Spera introduced a construction principle for divisible designs. Using this method, we get series of divisible designs from finite…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Expression and functional analysis of genes deregulated in mouse placental overgrowth models: Car2 and Ncam1 by Singh, Umashankar, Sun, Tong, Shi, Wei, Schulz, Ralph, Nuber, Ulrike A., Varanou, Aikaterini, Hemberger, Myriam C., Elliott, Rosemary W., Ohta, Hiroshi, Wakayama, Teruhiko, Fundele, Reinald

    Published in Developmental dynamics (01-12-2005)
    “…Different causes, such as maternal diabetes, cloning by nuclear transfer, interspecific hybridization, and deletion of some genes such as Esx1, Ipl, or Cdkn1c,…”
    Get full text
    Journal Article
  9. 9

    Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction by Colbeck, Emily J, Jones, Emma, Hindley, James P, Smart, Kathryn, Schulz, Ralph, Browne, Molly, Cutting, Scott, Williams, Anwen, Parry, Lee, Godkin, Andrew, Ware, Carl F, Ager, Ann, Gallimore, Awen

    Published in Cancer immunology research (01-11-2017)
    “…T-cell infiltration into tumors represents a critical bottleneck for immune-mediated control of cancer. We previously showed that this bottleneck can be…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell Activation by Yakoub, Abraam M., Schulz, Ralph, Seiffert, Martina, Sadek, Mark

    Published in Scientific reports (12-07-2018)
    “…Apoptosis is an important physiological process in development and disease. Apoptotic cells (ACs) are a major source of self-antigens, but ACs usually evade…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice by Hanna, Bola S., Yazdanparast, Haniyeh, Demerdash, Yasmin, Roessner, Philipp M., Schulz, Ralph, Lichter, Peter, Stilgenbauer, Stephan, Seiffert, Martina

    Published in Haematologica (Roma) (05-03-2020)
    “…Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor approved for the treatment of multiple B-cell malignancies, including chronic lymphocytic leukemia…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Abstract LB-083: Targeting IRAK4 disrupts inflammatory pathways and tumor microenvironment in chronic lymphocytic leukemia regardless MYD88 mutational status by Rosich, Laia, Gimenez, Neus, Schulz, Ralph, Higashi, Morihiro, Aymerich, Marta, Lopez, Monica, Juan, Manel, Seiffert, Martina, Campo, Elias, Colomer, Dolors

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…BACKGROUND & AIM. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in Toll-like receptor (TLR) signal transduction and the innate…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia by Giménez Carabaza, Neus, Laia, Rosich, Ralph, Schulz, Morihiro, Higashi, Aymerich, Marta, Villamor, Neus, Delgado, Julio, Juan, Manel, Lopez-Guerra, Monica, Campo, Elias, Seiffert, Martina, Colomer, Dolors

    Published in Blood (29-11-2018)
    “…Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a critical role in Toll-like receptor (TLR) signal transduction and the innate immune responses…”
    Get full text
    Journal Article
  18. 18

    CLL Exosome-Derived Y RNA hY4 Induces TLR7/8-Mediated Inflammation and PD-L1 Expression in Monocytes by Haderk, Franziska, Llao Cid, Laura, Iskar, Murat, Schulz, Ralph, Goebel, Maria, Duerig, Jan, Stilgenbauer, Stephan, Zapatka, Marc, Lichter, Peter, Seiffert, Martina

    Published in Blood (02-12-2016)
    “…Chronic lymphocytic leukemia (CLL) is a B-cell malignancy associated with an inflammatory milieu and impaired anti-tumor immunity. Both in human CLL samples…”
    Get full text
    Journal Article
  19. 19
  20. 20